U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07104929) titled 'Beta Glucan 500 and Biological Age and Immune Age' on July 28.
Brief Summary: The primary purpose of this study is to evaluate the effects of BWH Labs - Beta Glucan 500 on biomarkers of biological and immune age among healthy adults.
A single-arm, open-label prospective study will be conducted evaluating the impact of 12 weeks of supplementation with two capsules daily of Beta Glucan 500 on a variety of validated markers of biological and immune age on the comprehensive TruAge panel (TruDiagnostics, Lexington, KY).
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Aging
Intervention:
DIETARY_SUPPLEMENT: Beta G...